Novel Topical Application of a Postbiotic, LactoSporin®, in Mild to Moderate Acne: A Randomized, Comparative Clinical Study to Evaluate its Efficacy, Tolerability and Safety

Acne vulgaris is a common skin disorder of pilosebaceous units. The therapy for mild-to-moderate acne includes topical antibiotics, benzoyl peroxide and retinoids. In this open-label, randomized monocentric study, we compared the efficacy of LactoSporin® 2% w/w cream with benzoyl peroxide in 64 male...

Full description

Saved in:
Bibliographic Details
Published inCosmetics (Basel) Vol. 7; no. 3; p. 70
Main Authors Majeed, Muhammed, Majeed, Shaheen, Nagabhushanam, Kalyanam, Mundkur, Lakshmi, Rajalakshmi, H., Shah, Kalpesh, Beede, Kirankumar
Format Journal Article
LanguageEnglish
Published MDPI AG 01.09.2020
Subjects
Online AccessGet full text
ISSN2079-9284
2079-9284
DOI10.3390/cosmetics7030070

Cover

Abstract Acne vulgaris is a common skin disorder of pilosebaceous units. The therapy for mild-to-moderate acne includes topical antibiotics, benzoyl peroxide and retinoids. In this open-label, randomized monocentric study, we compared the efficacy of LactoSporin® 2% w/w cream with benzoyl peroxide in 64 male and female subjects with mild-to-moderate acne for three weeks. The efficacy parameters were evaluated based on the dermatologist visual assessment and instrumental measurements using Sebumeter® MPA580, Antera 3DTM and VISIA CR 2.2 and subject self-assessment questionnaires. Adverse events were recorded throughout the study period. In order to understand the mechanism of action and properties of LactoSporin, the pH stability, thermostability, antimicrobial activity and 5-alpha reductase activity were evaluated in vitro. A significant improvement was observed in the dermatological assessment of closed comedones (p < 0.0001), open comedones (p = 0.0069) and papules count (p < 0.0001) in comparison to the baseline in both LactoSporin and benzoyl peroxide groups. The antera analysis showed significant improvement in redness (p < 0.0001) and elevation (p < 0.0001) (small and medium) in both the treatment groups. The sebumeter analysis showed a significant decrease in sebaceous secretion (p < 0.0001) for LactoSporin, which resulted in reduced oiliness, pimples, acne spots and redness around the acne spot. The product was found to be safe without any irritancy. LactoSporin was stable at an acidic pH and temperature range of 70 to 90 °C, with antimicrobial activity against various pathogenic bacteria, including Cutibacterium acnes. It was also a potent inhibitor of 5-alpha reductase activity. Thus, it can be concluded that the efficacy of LactoSporin is equivalent to benzoyl peroxide in the treatment of mild-to-moderate acne lesions and better than benzoyl peroxide for reducing the sebaceous secretion and oily, greasy nature of the skin, implying its efficacy in other sebohorriec conditions.
AbstractList Acne vulgaris is a common skin disorder of pilosebaceous units. The therapy for mild-to-moderate acne includes topical antibiotics, benzoyl peroxide and retinoids. In this open-label, randomized monocentric study, we compared the efficacy of LactoSporin[R] 2% w/w cream with benzoyl peroxide in 64 male and female subjects with mild-to-moderate acne for three weeks. The efficacy parameters were evaluated based on the dermatologist visual assessment and instrumental measurements using Sebumeter[R] MPA580, Antera 3D (TM) and VISIA CR 2.2 and subject self-assessment questionnaires. Adverse events were recorded throughout the study period. In order to understand the mechanism of action and properties of LactoSporin, the pH stability, thermostability, antimicrobial activity and 5-alpha reductase activity were evaluated in vitro. A significant improvement was observed in the dermatological assessment of closed comedones (p < 0.0001), open comedones (p = 0.0069) and papules count (p < 0.0001) in comparison to the baseline in both LactoSporin and benzoyl peroxide groups. The antera analysis showed significant improvement in redness (p < 0.0001) and elevation (p < 0.0001) (small and medium) in both the treatment groups. The sebumeter analysis showed a significant decrease in sebaceous secretion (p < 0.0001) for LactoSporin, which resulted in reduced oiliness, pimples, acne spots and redness around the acne spot. The product was found to be safe without any irritancy. LactoSporin was stable at an acidic pH and temperature range of 70 to 90 [degrees]C, with antimicrobial activity against various pathogenic bacteria, including Cutibacterium acnes. It was also a potent inhibitor of 5-alpha reductase activity. Thus, it can be concluded that the efficacy of LactoSporin is equivalent to benzoyl peroxide in the treatment of mild-to-moderate acne lesions and better than benzoyl peroxide for reducing the sebaceous secretion and oily, greasy nature of the skin, implying its efficacy in other sebohorriec conditions.
Acne vulgaris is a common skin disorder of pilosebaceous units. The therapy for mild-to-moderate acne includes topical antibiotics, benzoyl peroxide and retinoids. In this open-label, randomized monocentric study, we compared the efficacy of LactoSporin® 2% w/w cream with benzoyl peroxide in 64 male and female subjects with mild-to-moderate acne for three weeks. The efficacy parameters were evaluated based on the dermatologist visual assessment and instrumental measurements using Sebumeter® MPA580, Antera 3DTM and VISIA CR 2.2 and subject self-assessment questionnaires. Adverse events were recorded throughout the study period. In order to understand the mechanism of action and properties of LactoSporin, the pH stability, thermostability, antimicrobial activity and 5-alpha reductase activity were evaluated in vitro. A significant improvement was observed in the dermatological assessment of closed comedones (p < 0.0001), open comedones (p = 0.0069) and papules count (p < 0.0001) in comparison to the baseline in both LactoSporin and benzoyl peroxide groups. The antera analysis showed significant improvement in redness (p < 0.0001) and elevation (p < 0.0001) (small and medium) in both the treatment groups. The sebumeter analysis showed a significant decrease in sebaceous secretion (p < 0.0001) for LactoSporin, which resulted in reduced oiliness, pimples, acne spots and redness around the acne spot. The product was found to be safe without any irritancy. LactoSporin was stable at an acidic pH and temperature range of 70 to 90 °C, with antimicrobial activity against various pathogenic bacteria, including Cutibacterium acnes. It was also a potent inhibitor of 5-alpha reductase activity. Thus, it can be concluded that the efficacy of LactoSporin is equivalent to benzoyl peroxide in the treatment of mild-to-moderate acne lesions and better than benzoyl peroxide for reducing the sebaceous secretion and oily, greasy nature of the skin, implying its efficacy in other sebohorriec conditions.
Audience Academic
Author Majeed, Shaheen
Mundkur, Lakshmi
Nagabhushanam, Kalyanam
Beede, Kirankumar
Majeed, Muhammed
Rajalakshmi, H.
Shah, Kalpesh
Author_xml – sequence: 1
  givenname: Muhammed
  surname: Majeed
  fullname: Majeed, Muhammed
– sequence: 2
  givenname: Shaheen
  orcidid: 0000-0001-6400-8245
  surname: Majeed
  fullname: Majeed, Shaheen
– sequence: 3
  givenname: Kalyanam
  orcidid: 0000-0001-9470-4110
  surname: Nagabhushanam
  fullname: Nagabhushanam, Kalyanam
– sequence: 4
  givenname: Lakshmi
  orcidid: 0000-0003-2928-1726
  surname: Mundkur
  fullname: Mundkur, Lakshmi
– sequence: 5
  givenname: H.
  surname: Rajalakshmi
  fullname: Rajalakshmi, H.
– sequence: 6
  givenname: Kalpesh
  surname: Shah
  fullname: Shah, Kalpesh
– sequence: 7
  givenname: Kirankumar
  orcidid: 0000-0001-7190-6385
  surname: Beede
  fullname: Beede, Kirankumar
BookMark eNp1kc1q3DAUhU1JoWmafZeCbmdayZJlq7thmDSBSVs66dpc6ycoyL7GUgbch8pD9MmimSmlBLrSRfec7widt8XZgIMtiveMfuRc0U8aY2-T17GmnNKavirOS1qrpSobcfbP_Ka4jPGBUsp4WXGmzounr7i3gdzh6DUEshrHkIfkcSDoCJDvGFPnMbMXZAs64W7EyQ-_nxbED-TWB0MSkls0doJkyUoP9jNZkR8wGOz9L2sWZI39CHnr95asgx-OQbv0aOaDdbOH8Hiw-hTJxrm81fMiPyhkYueDTzPJMLIDZ9P8rnjtIER7-ee8KH5ebe7W18vtty8369V2qXmt0pJxzk3lNKXSGNbVgjPJrWuaRmolpTQArpJWQiPLTpYVSG5M54SsS1WJSvGL4ubENQgP7Tj5Hqa5RfDt8QKn-xam_CnBtkCZggwWHauFVUJRaktdN9wIWgrhMuvDiXUPWe4Hh2kC3fuo25UUsmKyVCyr6EmlJ4xxsu5vKqPtoeT2ZcnZIl9YtE_H7nKAD_83PgOYZLFX
CitedBy_id crossref_primary_10_1080_19490976_2022_2117508
crossref_primary_10_20479_bursauludagziraat_1485713
crossref_primary_10_3390_fermentation9030264
crossref_primary_10_3390_microorganisms11061420
crossref_primary_10_3390_ijms22084228
crossref_primary_10_3390_cosmetics9030065
crossref_primary_10_3390_antibiotics12121698
crossref_primary_10_4014_jmb_2403_03010
crossref_primary_10_1111_ics_12766
crossref_primary_10_33320_maced_pharm_bull_2022_68_01_002
crossref_primary_10_1080_09546634_2023_2296855
crossref_primary_10_3389_fsufs_2022_887642
crossref_primary_10_1007_s12602_023_10175_2
crossref_primary_10_2174_0113816128335414240828105229
crossref_primary_10_1080_14728214_2022_2110239
crossref_primary_10_1093_jambio_lxad274
crossref_primary_10_1186_s13040_025_00433_0
crossref_primary_10_1097_MD_0000000000040931
crossref_primary_10_2147_CCID_S403418
crossref_primary_10_1002_biof_1975
crossref_primary_10_3390_app12189151
crossref_primary_10_1080_10408398_2020_1865260
crossref_primary_10_3390_cosmetics7040076
crossref_primary_10_1007_s12275_022_00002_8
crossref_primary_10_2174_1573401319666230309122819
crossref_primary_10_4103_ijd_ijd_655_22
crossref_primary_10_3390_vaccines11040725
crossref_primary_10_1080_10408398_2022_2056727
crossref_primary_10_3389_fmicb_2023_1306192
crossref_primary_10_3390_nu16203559
crossref_primary_10_3390_biomedicines13040791
crossref_primary_10_1016_j_jddst_2024_105635
crossref_primary_10_1111_jam_15663
crossref_primary_10_1111_jocd_15809
crossref_primary_10_26599_FSHW_2022_9250217
crossref_primary_10_1016_j_procbio_2024_05_010
Cites_doi 10.1111/j.1529-8019.2006.00079.x
10.1016/B978-0-12-812475-8.00004-4
10.1111/1346-8138.14314
10.1016/j.clp.2012.12.002
10.1128/AEM.05576-11
10.4161/derm.3.1.13900
10.1126/science.1225152
10.1016/S0378-1097(03)00092-2
10.1007/s12275-008-0179-y
10.5694/mja16.00516
10.1111/pde.13261
10.1046/j.1472-765x.2001.00876.x
10.15171/hpp.2020.02
10.3390/ijms20194673
10.1111/j.1468-2494.2011.00647.x
10.1016/j.drudis.2016.10.017
10.1590/abd1806-4841.20142100
10.1016/j.clim.2015.05.014
10.1016/j.ijwd.2015.02.001
10.1007/s007950100002
10.1136/bmj.1.6171.1109
10.1111/bjd.13462
10.1016/S0140-6736(98)01046-0
10.1111/j.1468-3083.2011.04374.x
10.1016/S0168-1605(01)00560-8
10.3390/jcm8070987
10.3390/molecules21081063
10.1016/j.jaad.2006.08.048
10.1016/0168-1605(95)00055-0
10.1210/edrv.21.4.0404
10.3389/fimmu.2013.00507
10.1038/nrmicro2537
10.1517/14740338.2013.740456
10.1021/acs.biomac.9b00939
10.1074/jbc.M112.359067
10.1007/978-3-642-20838-6_9
10.1001/jamadermatol.2017.1297
10.1159/000338978
10.1128/AAC.33.3.326
10.1111/j.1600-0846.2011.00605.x
10.1016/j.tifs.2018.03.009
10.1086/432067
10.1080/00015550310016463
ContentType Journal Article
Copyright COPYRIGHT 2020 MDPI AG
Copyright_xml – notice: COPYRIGHT 2020 MDPI AG
DBID AAYXX
CITATION
DOA
DOI 10.3390/cosmetics7030070
DatabaseName CrossRef
DOAJ Open Access Full Text
DatabaseTitle CrossRef
DatabaseTitleList

CrossRef
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
DeliveryMethod fulltext_linktorsrc
Discipline Engineering
EISSN 2079-9284
ExternalDocumentID oai_doaj_org_article_a019a8864b174e94900e2c783d40244f
A646516291
10_3390_cosmetics7030070
GeographicLocations India
GeographicLocations_xml – name: India
GroupedDBID 5VS
8FE
8FH
AADQD
AAFWJ
AAHBH
AAYXX
ADBBV
AFKRA
AFPKN
AFZYC
ALMA_UNASSIGNED_HOLDINGS
BBNVY
BCNDV
BENPR
BHPHI
CCPQU
CITATION
GROUPED_DOAJ
HCIFZ
IAO
KQ8
LK8
M7P
MODMG
M~E
OK1
PHGZM
PHGZT
PIMPY
PQGLB
PROAC
PUEGO
ID FETCH-LOGICAL-c379t-1333d5fc006dd1b743163ef8886c9666daaf56e6a862b625a63ddbf4672954593
IEDL.DBID DOA
ISSN 2079-9284
IngestDate Wed Aug 27 01:30:11 EDT 2025
Tue Jun 17 22:05:05 EDT 2025
Thu Apr 24 22:56:52 EDT 2025
Wed Sep 10 05:54:06 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 3
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c379t-1333d5fc006dd1b743163ef8886c9666daaf56e6a862b625a63ddbf4672954593
ORCID 0000-0001-7190-6385
0000-0001-9470-4110
0000-0001-6400-8245
0000-0003-2928-1726
OpenAccessLink https://doaj.org/article/a019a8864b174e94900e2c783d40244f
ParticipantIDs doaj_primary_oai_doaj_org_article_a019a8864b174e94900e2c783d40244f
gale_infotracmisc_A646516291
crossref_primary_10_3390_cosmetics7030070
crossref_citationtrail_10_3390_cosmetics7030070
PublicationCentury 2000
PublicationDate 2020-09-01
PublicationDateYYYYMMDD 2020-09-01
PublicationDate_xml – month: 09
  year: 2020
  text: 2020-09-01
  day: 01
PublicationDecade 2020
PublicationTitle Cosmetics (Basel)
PublicationYear 2020
Publisher MDPI AG
Publisher_xml – name: MDPI AG
References Yang (ref_27) 2014; 5
Fried (ref_33) 2006; 19
Lee (ref_28) 2001; 32
Mankoci (ref_42) 2019; 20
Tripathi (ref_34) 2013; 12
Messi (ref_25) 2003; 220
See (ref_10) 2018; 45
ref_19
Coughlin (ref_41) 2017; 34
ref_15
Wormser (ref_31) 2005; 41
Webster (ref_38) 2005; 76
Brown (ref_2) 1998; 351
Leyden (ref_24) 2004; 73
Cooper (ref_7) 2017; 206
Tester (ref_16) 2012; 1
Cleveland (ref_22) 2001; 71
ref_29
Rad (ref_53) 2020; 10
Jappe (ref_9) 2003; 83
Vermeer (ref_44) 2012; 287
Tanghetti (ref_8) 2013; 6
Patel (ref_20) 2013; 40
Bagatin (ref_4) 2014; 89
Nast (ref_12) 2012; 26
Garcia (ref_18) 2018; 75
ref_32
Sakuma (ref_50) 2012; 25
Naik (ref_17) 2012; 337
Palm (ref_40) 2015; 159
Cobacho (ref_30) 2017; 22
Fluhr (ref_13) 2010; 8
ref_37
Deplewski (ref_47) 2000; 21
Brown (ref_45) 2014; 4
Kober (ref_39) 2015; 1
Kanlayavattanakul (ref_35) 2011; 33
Cunliffe (ref_1) 1979; 1
Strauss (ref_11) 2007; 56
Decker (ref_14) 1989; 33
Tan (ref_3) 2015; 172
ref_43
Dobson (ref_26) 2012; 78
Kim (ref_51) 2013; 19
Adler (ref_23) 2017; 153
Grice (ref_52) 2011; 9
Abee (ref_21) 1995; 28
ref_49
Bagatin (ref_36) 2014; 13
Toyoda (ref_5) 2001; 34
Kang (ref_46) 2009; 47
ref_6
Makrantonaki (ref_48) 2011; 3
References_xml – volume: 19
  start-page: 237
  year: 2006
  ident: ref_33
  article-title: Psychological problems in the acne patient
  publication-title: Dermatol. Ther.
  doi: 10.1111/j.1529-8019.2006.00079.x
– ident: ref_32
– ident: ref_49
  doi: 10.1016/B978-0-12-812475-8.00004-4
– volume: 45
  start-page: 522
  year: 2018
  ident: ref_10
  article-title: Optimizing the use of topical retinoids in Asian acne patients
  publication-title: J. Dermatol.
  doi: 10.1111/1346-8138.14314
– volume: 40
  start-page: 11
  year: 2013
  ident: ref_20
  article-title: Therapeutic use of prebiotics, probiotics, and postbiotics to prevent necrotizing enterocolitis: What is the current evidence?
  publication-title: Clin. Perinatol.
  doi: 10.1016/j.clp.2012.12.002
– volume: 78
  start-page: 1
  year: 2012
  ident: ref_26
  article-title: Bacteriocin production: A probiotic trait?
  publication-title: Appl. Environ. Microbiol.
  doi: 10.1128/AEM.05576-11
– volume: 3
  start-page: 41
  year: 2011
  ident: ref_48
  article-title: An update on the role of the sebaceous gland in the pathogenesis of acne
  publication-title: Dermatoendocrinol
  doi: 10.4161/derm.3.1.13900
– volume: 337
  start-page: 1115
  year: 2012
  ident: ref_17
  article-title: Compartmentalized control of skin immunity by resident commensals
  publication-title: Science
  doi: 10.1126/science.1225152
– volume: 220
  start-page: 121
  year: 2003
  ident: ref_25
  article-title: Bacteriocin-like substance (BLS) production in Aeromonas hydrophila water isolates
  publication-title: FEMS Microbiol. Lett.
  doi: 10.1016/S0378-1097(03)00092-2
– volume: 47
  start-page: 101
  year: 2009
  ident: ref_46
  article-title: Antimicrobial activity of enterocins from Enterococcus faecalis SL-5 against Propionibacterium acnes, the causative agent in acne vulgaris, and its therapeutic effect
  publication-title: J. Microbiol.
  doi: 10.1007/s12275-008-0179-y
– volume: 206
  start-page: 41
  year: 2017
  ident: ref_7
  article-title: Modern management of acne
  publication-title: Med. J. Aust.
  doi: 10.5694/mja16.00516
– volume: 34
  start-page: 661
  year: 2017
  ident: ref_41
  article-title: The preadolescent acne microbiome: A prospective, randomized, pilot study investigating characterization and effects of acne therapy
  publication-title: Pediatr. Dermatol.
  doi: 10.1111/pde.13261
– volume: 8
  start-page: S24
  year: 2010
  ident: ref_13
  article-title: Antibiotics, azelaic acid and benzoyl peroxide in topical acne therapy
  publication-title: J. Dtsch. Dermatol. Ges.
– volume: 32
  start-page: 146
  year: 2001
  ident: ref_28
  article-title: Partial characterization of polyfermenticin SCD, a newly identified bacteriocin of Bacillus polyfermenticus
  publication-title: Lett. Appl. Microbiol.
  doi: 10.1046/j.1472-765x.2001.00876.x
– volume: 10
  start-page: 3
  year: 2020
  ident: ref_53
  article-title: Postbiotics as novel health-promoting ingredients in functional foods
  publication-title: Health Promot. Perspect.
  doi: 10.15171/hpp.2020.02
– volume: 1
  start-page: 5
  year: 2012
  ident: ref_16
  article-title: The role of pre-and probiotics in skin care
  publication-title: Inside Cosmeceuticals
– ident: ref_19
  doi: 10.3390/ijms20194673
– volume: 33
  start-page: 289
  year: 2011
  ident: ref_35
  article-title: Therapeutic agents and herbs in topical application for acne treatment
  publication-title: Int. J. Cosmet. Sci.
  doi: 10.1111/j.1468-2494.2011.00647.x
– volume: 22
  start-page: 234
  year: 2017
  ident: ref_30
  article-title: The next generation of antimicrobial peptides (AMPs) as molecular therapeutic tools for the treatment of diseases with social and economic impacts
  publication-title: Drug Discov. Today
  doi: 10.1016/j.drudis.2016.10.017
– volume: 89
  start-page: 428
  year: 2014
  ident: ref_4
  article-title: Acne vulgaris: Prevalence and clinical forms in adolescents from Sao Paulo, Brazil
  publication-title: An. Bras. Dermatol.
  doi: 10.1590/abd1806-4841.20142100
– volume: 159
  start-page: 122
  year: 2015
  ident: ref_40
  article-title: Immune-microbiota interactions in health and disease
  publication-title: Clin. Immunol.
  doi: 10.1016/j.clim.2015.05.014
– volume: 1
  start-page: 85
  year: 2015
  ident: ref_39
  article-title: The effect of probiotics on immune regulation, acne, and photoaging
  publication-title: Int. J. Women Dermatol.
  doi: 10.1016/j.ijwd.2015.02.001
– volume: 34
  start-page: 29
  year: 2001
  ident: ref_5
  article-title: Pathogenesis of acne
  publication-title: Med. Electron. Microsc.
  doi: 10.1007/s007950100002
– volume: 1
  start-page: 1109
  year: 1979
  ident: ref_1
  article-title: Prevalence of facial acne vulgaris in late adolescence and in adults
  publication-title: Br. Med. J.
  doi: 10.1136/bmj.1.6171.1109
– volume: 5
  start-page: 241
  year: 2014
  ident: ref_27
  article-title: Antibacterial activities of bacteriocins: Application in foods and pharmaceuticals
  publication-title: Front. Microbiol.
– volume: 172
  start-page: 3
  year: 2015
  ident: ref_3
  article-title: A global perspective on the epidemiology of acne
  publication-title: Br. J. Dermatol.
  doi: 10.1111/bjd.13462
– volume: 351
  start-page: 1871
  year: 1998
  ident: ref_2
  article-title: Acne vulgaris
  publication-title: Lancet
  doi: 10.1016/S0140-6736(98)01046-0
– volume: 26
  start-page: 1
  year: 2012
  ident: ref_12
  article-title: European evidence-based (S3) guidelines for the treatment of acne
  publication-title: J. Eur. Acad. Dermatol. Venereol.
  doi: 10.1111/j.1468-3083.2011.04374.x
– volume: 73
  start-page: 6
  year: 2004
  ident: ref_24
  article-title: Antibiotic resistance in the topical treatment of acne vulgaris
  publication-title: Cutis
– volume: 71
  start-page: 1
  year: 2001
  ident: ref_22
  article-title: Bacteriocins: Safe, natural antimicrobials for food preservation
  publication-title: Int. J. Food Microbiol.
  doi: 10.1016/S0168-1605(01)00560-8
– ident: ref_37
  doi: 10.3390/jcm8070987
– ident: ref_15
  doi: 10.3390/molecules21081063
– volume: 76
  start-page: 4
  year: 2005
  ident: ref_38
  article-title: The pathophysiology of acne
  publication-title: Cutis
– volume: 56
  start-page: 651
  year: 2007
  ident: ref_11
  article-title: Guidelines of care for acne vulgaris management
  publication-title: J. Am. Acad. Dermatol.
  doi: 10.1016/j.jaad.2006.08.048
– volume: 28
  start-page: 169
  year: 1995
  ident: ref_21
  article-title: Bacteriocins: Modes of action and potentials in food preservation and control of food poisoning
  publication-title: Int. J. Food Microbiol.
  doi: 10.1016/0168-1605(95)00055-0
– volume: 21
  start-page: 363
  year: 2000
  ident: ref_47
  article-title: Role of hormones in pilosebaceous unit development
  publication-title: Endocr. Rev.
  doi: 10.1210/edrv.21.4.0404
– volume: 4
  start-page: 507
  year: 2014
  ident: ref_45
  article-title: Staphylococcus aureus Colonization: Modulation of Host Immune Response and Impact on Human Vaccine Design
  publication-title: Front. Immunol.
  doi: 10.3389/fimmu.2013.00507
– volume: 9
  start-page: 244
  year: 2011
  ident: ref_52
  article-title: The skin microbiome
  publication-title: Nat. Rev. Microbiol.
  doi: 10.1038/nrmicro2537
– volume: 12
  start-page: 39
  year: 2013
  ident: ref_34
  article-title: Side effects of common acne treatments
  publication-title: Expert Opin. Drug Saf.
  doi: 10.1517/14740338.2013.740456
– volume: 20
  start-page: 4096
  year: 2019
  ident: ref_42
  article-title: Bacterial Membrane Selective Antimicrobial Peptide-Mimetic Polyurethanes: Structure–Property Correlations and Mechanisms of Action
  publication-title: Biomacromolecules
  doi: 10.1021/acs.biomac.9b00939
– ident: ref_6
– ident: ref_29
– volume: 13
  start-page: 162
  year: 2014
  ident: ref_36
  article-title: Acne vulgaris: An inflammatory disease even before the onset of clinical lesions
  publication-title: Inflamm. Allergy-Drug Targets (Former. Curr. Drug Targets-Inflamm. Allergy)
– volume: 287
  start-page: 34120
  year: 2012
  ident: ref_44
  article-title: Conformational flexibility determines selectivity and antibacterial, antiplasmodial, and anticancer potency of cationic alpha-helical peptides
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.M112.359067
– ident: ref_43
  doi: 10.1007/978-3-642-20838-6_9
– volume: 6
  start-page: 27
  year: 2013
  ident: ref_8
  article-title: The role of inflammation in the pathology of acne
  publication-title: J. Clin. Aesthetic Dermatol.
– volume: 153
  start-page: 810
  year: 2017
  ident: ref_23
  article-title: Antibiotic Resistance in Acne Treatment
  publication-title: JAMA Dermatol.
  doi: 10.1001/jamadermatol.2017.1297
– volume: 25
  start-page: 227
  year: 2012
  ident: ref_50
  article-title: Oily skin: An overview
  publication-title: Skin Pharmacol. Physiol.
  doi: 10.1159/000338978
– volume: 33
  start-page: 326
  year: 1989
  ident: ref_14
  article-title: Role of lipids in augmenting the antibacterial activity of benzoyl peroxide against Propionibacterium acnes
  publication-title: Antimicrob. Agents Chemother.
  doi: 10.1128/AAC.33.3.326
– volume: 19
  start-page: e45
  year: 2013
  ident: ref_51
  article-title: Sebum, acne, skin elasticity, and gender difference–which is the major influencing factor for facial pores?
  publication-title: Skin Res. Technol.
  doi: 10.1111/j.1600-0846.2011.00605.x
– volume: 75
  start-page: 105
  year: 2018
  ident: ref_18
  article-title: Postbiotics: An evolving term within the functional foods field
  publication-title: Trends Food Sci. Technol.
  doi: 10.1016/j.tifs.2018.03.009
– volume: 41
  start-page: 577
  year: 2005
  ident: ref_31
  article-title: Antibiotics in Laboratory Medicine, Edited by Victor Lorain Philadelphia: Lippincott Williams & Wilkins, 2005 832 pp., illustrated. $199.00 (cloth)
  publication-title: Clin. Infect. Dis.
  doi: 10.1086/432067
– volume: 83
  start-page: 241
  year: 2003
  ident: ref_9
  article-title: Pathological mechanisms of acne with special emphasis on Propionibacterium acnes and related therapy
  publication-title: Acta Derm. Venereol.
  doi: 10.1080/00015550310016463
SSID ssj0001325319
Score 2.3758147
Snippet Acne vulgaris is a common skin disorder of pilosebaceous units. The therapy for mild-to-moderate acne includes topical antibiotics, benzoyl peroxide and...
SourceID doaj
gale
crossref
SourceType Open Website
Aggregation Database
Enrichment Source
Index Database
StartPage 70
SubjectTerms Acne
Allergy
antiacne
Antiacne agents
benzoyl peroxide
Care and treatment
Composition
LactoSporin
Methods
postbiotics
primary skin irritation patch test
Skin
Testing
Title Novel Topical Application of a Postbiotic, LactoSporin®, in Mild to Moderate Acne: A Randomized, Comparative Clinical Study to Evaluate its Efficacy, Tolerability and Safety
URI https://doaj.org/article/a019a8864b174e94900e2c783d40244f
Volume 7
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3LTtwwFLUqdl1ULQV1KKC7YIM00YQ49sTsUjQIVYUFD4ld5KcUKSSICUjDR_ERfFnvTQJELOimy0SOY9nX9jnxzTmM7QmfKaO4jtw8zqI0tT5SwpiIu9h4JBSIGLpsizN5cpX-vhbXI6svygnr5YH7jptpxCA6y2RqEDt7lao49omdZ9wh80nTQKtvrOIRmeq-rvCEgqs_l-TI62e2Wd7Qb4FLCvGYvIlH-1An1z8syqPt5fgr-zLgQsj79nxjn3y9zj6P1AK_s6ez5sFXcNncUsdC_nb0DE0ADeS7a8oGK5jCH7LRIQfzsn5-mkJZw2lZOWgb6MzPEGBCbmt_CDmc69o1N-Wjd1M4etMCh0ExtAJKNVzRo4teGdxD2S5hQdoT2q6m2KAKa-ySbFeAlcGFDr5dbbCr48Xl0Uk02C1Els8VmdJz7kSwOA-dOzAELST3ASmytEiKpNM6COmlRhJkkDZpyZ0zAVdaOisUim-ytbqp_Q8G0iJhFyKYFOEWUR4ZEscdXYdEJGbCZi-dX9hBi5wsMaoCOQkNV_F-uCZs__WJ216H44Oyv2g8X8uRgnZ3A-OqGOKq-FdcTdg2RUNB8xybZnHW2SKXZB0vE3Ww9T_e8ZO-ElAWEKWsbbO19u7e7yDGac1uF85_ASmX-kU
linkProvider Directory of Open Access Journals
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Novel+Topical+Application+of+a+Postbiotic%2C+LactoSporin%C2%AE%2C+in+Mild+to+Moderate+Acne%3A+A+Randomized%2C+Comparative+Clinical+Study+to+Evaluate+its+Efficacy%2C+Tolerability+and+Safety&rft.jtitle=Cosmetics+%28Basel%29&rft.au=Muhammed+Majeed&rft.au=Shaheen+Majeed&rft.au=Kalyanam+Nagabhushanam&rft.au=Lakshmi+Mundkur&rft.date=2020-09-01&rft.pub=MDPI+AG&rft.eissn=2079-9284&rft.volume=7&rft.issue=3&rft.spage=70&rft_id=info:doi/10.3390%2Fcosmetics7030070&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_a019a8864b174e94900e2c783d40244f
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2079-9284&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2079-9284&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2079-9284&client=summon